COVID Updates and all the latest additions to the IHIF COVID-19 Toolkit

The US Food and Drug Administration (FDA) plans to pursue five areas for near-term focus and implementation in terms of improving the agency’s responsiveness to the coronavirus pandemic as well as future public health emergencies ...
Read more➔ (Source: Emergo)
Small Business Restart Grant Program Expanded
The Indiana Economic Development Corp. has announced what it is calling a "significant expansion" of a program to help small businesses recover from the pandemic. The expansion will add $60 million to the Indiana Small Business Restart Grant program, allowing businesses to seek reimbursement for certain expenses incurred over the past year. Read More (Source: Inside Indiana Business)
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the expansion of their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs in Moderna’s pipeline, at Catalent’s biologics facility in Bloomington, Indiana.
Read More (Source: BusinessWire)
Greenlight Guru Selected for National COVID Testing Program
Indianapolis-based Greenlight Guru has been chosen to assist with the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Tech program to boost the development of technologies used for COVID-19 testing. The company is using its quality management software platform to help participants speed up the process toward commercialization. Director of Global Partnerships Connor Remaley says being selected for the program is an affirmation of the company's efforts.
Read More (Source: Inside Indiana Business)
With COVID-19 vaccines now available, get the facts on vaccine development. Learn more about the scientific rigor that goes into developing a vaccine, and how the vaccine process is safe and effective.
Member News
BioFutures 2021 Now Available

IHIF’s annual magazine, BioFutures 2021, is now available! To view a digital copy, please click here.

IHIF would like to thank our partners at the Indianapolis Business Journal and all of our advertisers for their help in making this year’s edition possible.

If you would like to advertise in next year’s edition (publishing in March 2022) or if you have a suggestion for an article or topic you would like us to explore, please contact IHIF.
Worth a read
Data Shows Record Growth in Indiana Life Sciences Sector
Indiana's life sciences industry continued to grow in 2020 despite the pandemic, according to new data from the Indiana Business Research center at the IU Kelley School of Business. BioCrossroads says the sector, which includes nearly 2,300 companies, generated $80 billion in economic impact last year. Read More (Soure: BioCrossroads and Inside Indiana Business)
Life Sciences Sector Records $9B in Investment, Capital
BioCrossroads has issued a new report showing Indiana’s life sciences companies accessed more than $9 billion in capital in 2020. The Indiana Life Sciences Capital 2020 annual report shows the funding comes from a variety of sources including federal research and small business grants, venture capital, initial public offerings, and mergers and acquisitions. Read More(Soure: BioCrossroads and Inside Indiana Business)
Vital Signs of the Medical Device Industry
The medical device industry is no stranger to change, but the COVID-19 pandemic has meant unprecedented levels of disruption across the board. Download "Vital Signs of the Medical Device Industry" to see what industry leaders have done in the face of upheaval and the new trends you can utilize to improve adaptability at your organization.
Name Change for Medical Tech Company
West Lafayette-based medical contract research company Bioanalytical Systems Inc. has changed its corporate name to Inotiv Inc. The move also includes a change to the ticker symbol on Nasdaq to NOTV. Read More
BASi Adding Pharmacology Testing Options
West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is growing its platform. The contract research services company plans to expand its offerings by adding cardiovascular safety pharmacology testing, a move it says is nearly a year in the making. Read More (Source: Inside Indiana Business)
New Inotiv Partnership to Focus on Liver Disease Therapies
West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) is partnering with a Japanese biopharmaceutical company to bolster Inotiv’s drug discovery research services for treatments of liver disease. The Indiana company says it will use PhoenixBio Co. Ltd’s proprietary PXB-mouse research model. Read More (Source: Inside Indiana Business)
Ivy Tech VP Named to National Infrastructure Panel
A vice president at Ivy Tech Community College has been appointed to a panel focused on national economic recovery policies. The college says Sue Smith will be part of the national infrastructure panel that is tasked with advising the Biden administration on it's "Build Back Better" initiative and other infrastructure proposals. Read More (Source: Inside Indiana Business)
One specific protein may be a master regulator for changing how cancer cells consume nutrients from their environments, preventing cell death and increasing the likelihood the cancer could spread, a study from the University of Notre Dame has shown.
Read more (Source: University of Notre Dame)
Two professors from Purdue University have developed BioEnthesis, an implant that uses stem cells from patients to heal rotator cuff injuries.
Full Story: Becker's Spine Review (4/5)  
Welcome New IHIF Members!
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!

Featured New Member
Femtera Laboratories LLC strives to innovate next-generation diagnostics for severe diseases, especially for simultaneous detection of multiple types of early-stage cancers. The accurate, non-invasive and affordable laboratory-developed tests (LDTs) the company works on are based on the cutting-edge metabolomics and high-resolution accurate mass spectrometry (HRAM) techniques. In addition, the company has been providing certain high-end research-use-only (RUO) testing services to support related research institutions/ hospitals.

Founded in March 2016, the company is currently located in the Biotechnology Research & Training Center of the Indiana University School of Medicine (IUSM) in Indianapolis, Indiana. Its technical team is comprised of highly skilled researchers hailing from multidisciplinary backgrounds. With unique combined expertise in academic research, industrial R&D and commercial testing services, the team is able to bridge the gap between scientific findings and commercialization. Femtera further enhances its strengths by working with a group of highly qualified consultants and collaborators.

IHIF's Policy Corner
What We're Following at Home and on the Hill



IHIF Actions
  • Joined multi-state comment letter on MACPAC about their differential rebate proposal for accelerated approvals.
IHIF Announces Senator Todd Young as 2020 Legislator of the Year
The Indiana Health Industry Forum, a statewide bio + med tech trade association, has announced Senator Todd Young as the organization’s 2020 Legislator of the Year. From 2011-2017, Young was the U.S. Congressional Representative of Indiana’s 9th District. Elected to the U.S. Senate in 2016, Young serves on the committees for Commerce, Science, and Transportation, Foreign Relations, Finance, and Small Business and Entrepreneurship. Senator Young has been an advocate for patients with pre-existing conditions, increasing patient access to therapies and healthcare, and the improvement of public health. 

Read More (Source: IHIF)
BIO/CSBA Study Examines Impact of Foreign Reference Pricing


Why did BIO and the Council of State Bioscience Associations (CSBA) commission this study?
CSBA commissioned this study in order to examine the negative effects bills like the Lower Drug Costs Now Act of 2019 / HR3 and other foreign reference pricing models would have had, if had they been in place. This study was developed to help educate key stakeholders about the implications of foreign reference pricing models.
 
Who conducted this study?
The study was conducted by Vital Transformation, an international health economics firm.
 
What were the key findings of this study?
If a bill like the Lower Drug Costs Now Act / HR3 had been in place from 2009-2019:
 
  • Up to 68 approved innovative therapies that were developed by small / emerging biotechs during that timeframe would have been reduced to only 7, leaving critical health care gaps for millions of Americans.
 
  • New medicines for some of the most difficult conditions to treat, including in rare diseases, oncology, and neurology, would be disproportionately impacted.
 
  • Biopharmaceutical industry job losses alone would total nearly 191,000, with total job losses across the economy of more than 950,000 when indirect effects are included. 
 
  • These losses would be triggered by a sharp drop in U.S. biopharmaceutical industry earnings (a 62% reduction, or $125 billion in 2024 alone) as a result of such policy, leading to large reductions in established companies’ ability to invest in small and emerging biotechs, chilling drug development and forestalling treatments and cures for patients in need.
 
 
Where can I review the study?
Upcoming Events
Friday, April 30, 2021
8:30 am

Individual Tickets
No charge

Corporate Rooms
$100

RSVP by
April 27, 2021

Register online at
 
PANEL MODERATOR
John Russell
Health Care & Life Sciences Reporter
Indianapolis Business
Journal
The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in the life sciences. Each month a policymaker or a panel in the field of life sciences will be available to answer questions concerning the major challenges and opportunities in the industry. We hope you will join us.
 
Tuesday, April 20, 2021 – WEBINAR
11:00 am – noon
Diversity in Innovation
The United States Patent and Trademark Office (USPTO), in conjunction with the National Council for Expanding American Innovation (NCEAI), is developing a national strategy to build a more demographically, geographically, and economically inclusive innovation ecosystem. The USPTO has been specifically charged with producing a report concerning patenting and entrepreneurship activities among women, minorities, and veterans. In response to a recent call for public comment on the report, several Indiana organizations responded, outlining their efforts to increase diversity and inclusion (D&I) in the innovation space. Please join us as we hear from local leaders on the importance of D&I to the future of the life sciences, learn about some of the steps currently being taken to improve D&I in our community, and get their thoughts on where there is still more work to be done.
 
Introduction:
  • Kristin Jones, President and CEO, Indiana Health Industry Forum
Moderator:
  • Deborah Pollack-Milgate, Partner, Barnes & Thornburg LLP
Presenters:
  • Arvie Anderson, Senior Director, IP Policy and Procurement, Eli Lilly and Company
  • Jay McGill, Chief Operating Officer, Indiana Bioscience Research Institute
  • Julia Saltsgaver, Executive Director, Quality Connection
  • James Wilson, Assistant Regional Director, USPTO
The MidWest Drug Development Conference
Oct 4-5, 2021, Omaha, Nebraska

The MidWest Drug Development Conference is a highly focused event condensing the best therapeutic research from a vast region into a singular event.

More than a dozen major institutions will present some of their best therapeutic programs and assets. About 50 technologies, delivered in 10-minute presentations, will span a broad range of indications including: inflammatory diseases, infectious diseases, cancer, metabolic diseases, and cardiovascular disease.

The MidWest Drug Development Conference is ideal for pharmaceutical companies and investor groups looking to identify new therapeutic assets and partnering opportunities.

Registration for The Digital MedTech Conference is open! Taking place virtually on May 6, The Digital MedTech Conference is a great opportunity to gain insights from leading industry experts and partake in discussion about current and future challenges, opportunities and trends in the digital health and medical device sectors. Learn more.
BioCrossroads Frameworx: A look at Indiana's emerging radiopharmaceutical industry 

WHEN: Thursday, May 6, 2021 From 8:30 – 10:00 AM
WHERE: Zoom details will be emailed to you upon completion of registration.

Did you know the two largest commercial medical cyclotrons in the U.S. are right here in Indiana?
In our next virtual Frameworx session on May 6th, we will take a look at the cluster of radiopharmaceutical companies growing in the greater Indianapolis area. In this session,
we will provide an overview of the field, discuss how it’s impacting the life sciences community, and showcase some of the major players in this space.
Tiffany Olson, president, Cardinal Health Nuclear & Precision Health Solutions will deliver a keynote presentation. Following the keynote, Tiffany will join a panel discussion with Bernard Lambert, president and Chief Operating Officer of Telix Pharmaceuticals (US), Inc., and Dr. Kara Weatherman, clinical associate professor of pharmacy practice at Purdue University College of Pharmacy. The panel will be moderated by BioCrossroads’ senior vice president of external engagement, Brian Stemme.

With the industry preparing for increased activity around partnering events in 2021, due in part to the virtual and hybrid nature of hosted meetings, it will be critical to establish a strategic roadmap for engagement that accelerates the effectiveness of your business development efforts. 

Elevate your presence at BIO’s established portfolio of independent investor and partnering events and attract the attention of hundreds of business development leaders, licensing professionals and investors from across the globe. 

*Please note, IHIF Membership does not qualify for the BIO Member discounts.
BIO Digital
June 10-11, 14-18, 2021

Ready to expand your company's visibility and partnership opportunities beyond borders in 2021? Join the Innovation Stage, BIO Digital's new interactive forum showcasing the hottest companies in biotech!
How does it work? Fast-paced presentations and networking allow you to showcase your company, biotech region, or technology to a global audience of prospective partners ahead of BIO Digital Week. Early access programming June 10-11 includes the new can't-miss Global Marketplace, allowing state and international delegations to tell their stories, plus other exciting tracks that will help your company rise to new heights!
With several options to participate, explore the new Innovation Stage and how your company or organization can get involved.

Announcing the 2020 - 2021 IN Life Sciences Collaboration Conference Series!

Since 2006, CBLS has been presenting the Indiana Life Sciences Collaboration Conference Series, providing a forum for professionals in healthcare and life sciences to consider, discuss, and debate key business strategy issues. The conferences bring together leaders from industry, academia, government, and economic development communities. Join us in exploring business solutions and making new connections in the life sciences.
NEW FOR THIS YEAR....
This year's series will begin virtually, building upon great subjects and quality presenters just as in previous years. The November format is modified for a half-day schedule over a two day span. We are excited to leverage the highly ranked Kelley School of Business' online learning resources for educational and networking opportunities for the series!
Lessons Learned from the Pandemic
April 30, 2021
Working with International Distributors: The Good, The Bad, and the Ugly

May 20, 2021, 12:00 PM-1:00 PM




Creating and managing a distribution relationship in another country can be intimidating. 
  • How do you find and evaluate a good partner? 
  • What should be included in the contract? 
  • What are some common pitfalls? 
  • How do you minimize your business and legal risks? 

Don’t go it alone and learn by trial and error. This webinar will cover international distribution relationship do’s and don’ts and explain practical strategies to help you succeed in developing global partnerships.

We will discuss topics like: whether to allow the distributor to control local product registrations, how to plan for transition after termination, what does ‘exclusivity’ mean, practical documentary and structuring tips, and determining when it makes sense to form your own in-country presence and go direct.

FEATURED SPEAKER:       
Matt Levy, Partner, Faegre Drinker
Industry News
Cardinal Health Expanding Indy Presence
An Ohio-based radiopharmaceutical contract manufacturer is growing its operations in Indianapolis. Cardinal Health has announced plans for a multi-million-dollar expansion that will include the addition of nearly 100 jobs. Tiffany Olson, president of nuclear and precision health solutions at Cardinal, says the expansion is the result of an increasing demand for theranostics, which are used for both the diagnosis and treatment of a disease at the cellular level. Read More (Source: Inside Indiana Business)
BIO Business Solutions - Special Discounts for IHIF Members
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today! See the latest deals and offers from our BIO Business Solutions partners here
Featured Program
About UniFirst
Workwear/Cleanroom
UniFirst, a leading supplier of workwear programs for businesses big and small since 1936, provides a range of apparel from traditional uniforms and industrial wear to protective clothing and “corporate casual” attire. Serving over 275,000 customers throughout the United States and Canada, UniFirst outfits more than 1.5 million people in their work clothes each business day and offers customers rental, lease, and purchase programs to enhance their business image at the very best value.
IHIF Member Benefits

  • Uniform and facility service savings of 30-50%
  • Hygienically clean garments & UHF Chip technology
  • Dedicated customer service team
  • Customer favorable terms and conditions
  • No price increases for 3 years
  • Free lab coat pressing included with rental program
  • Free company and name emblems on initial installation
  • No upfront program investment
  • 1-week complimentary service upon new agreement execution
About IHIF Membership

Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.

Membership in IHIF offers a number of solutions:
  • Promote your business, locally, nationally, and globally.
  • Support the industry in the state and contribute directly to its growth and direction.
  • Find others who share your interests and build your business network.
  • Lend your voice to public policies that support innovation.
  • Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.

To complete a membership application, click here. 
Time to renew? Try it on-line! It's quick and easy! IHIF members can renew their memberships on-line at any time and update information in the Member Directory. Not an IHIF Member? Apply on-line or download an application packet now!